Lansforsakringar Fondforvaltning AB publ Decreases Stock Position in Cigna Group $CI

Lansforsakringar Fondforvaltning AB publ trimmed its position in shares of Cigna Group (NYSE:CI) by 65.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,537 shares of the health services provider’s stock after selling 2,878 shares during the quarter. Lansforsakringar Fondforvaltning AB publ’s holdings in Cigna Group were worth $443,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CI. Norges Bank acquired a new stake in shares of Cigna Group in the second quarter valued at about $1,110,426,000. Arrowstreet Capital Limited Partnership grew its stake in Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after acquiring an additional 492,045 shares in the last quarter. Balyasny Asset Management L.P. raised its holdings in Cigna Group by 1,057.2% in the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock valued at $133,803,000 after acquiring an additional 369,775 shares during the last quarter. Man Group plc raised its holdings in Cigna Group by 215.5% in the 2nd quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after acquiring an additional 363,510 shares during the last quarter. Finally, Corient Private Wealth LLC boosted its holdings in shares of Cigna Group by 257.4% during the 2nd quarter. Corient Private Wealth LLC now owns 389,637 shares of the health services provider’s stock worth $127,811,000 after purchasing an additional 280,616 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE CI opened at $284.31 on Thursday. The stock has a fifty day simple moving average of $279.33 and a 200-day simple moving average of $284.41. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock has a market cap of $75.95 billion, a PE ratio of 12.82, a P/E/G ratio of 0.97 and a beta of 0.27. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is 27.23%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CI shares. Barclays cut their price target on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a report on Friday, February 6th. Robert W. Baird dropped their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. Deutsche Bank Aktiengesellschaft lifted their price target on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. Jefferies Financial Group boosted their price target on shares of Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Finally, Mizuho set a $325.00 price objective on shares of Cigna Group in a research report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average price target of $330.63.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.